Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.37 |
| ▸ | RELA | Q04206 | 2/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14849207 | 0.86 | MAPT (0.36) | NPC1RAB9ASMN1; SMN2HPGDTSHR | |
| SCHEMBL26099756 | 0.84 | FBP1 (0.36) | NPC1RAB9ASMN1; SMN2HPGDTSHR | |
| SCHEMBL7955724 | 0.77 | LTA4H (0.53) | MEN1KMT2ANFKB1NFKB2RELA | |
| SCHEMBL20386511 | 0.77 | ALDH1A1 (0.39) | TSHRMEN1KMT2AOPRM1OPRL1 | |
| SCHEMBL2681787 | 0.77 | ALDH1A1 (0.39) | TSHRMEN1KMT2AOPRM1OPRL1 | |
| SCHEMBL10042854 | 0.74 | ALDH1A1 (0.38) | NPC1RAB9ASMN1; SMN2TSHRMEN1 | |
| SCHEMBL516394 | 0.74 | — | — | |
| SCHEMBL20385081 | 0.72 | MEN1 (0.52) | SMN1; SMN2HPGDMEN1KMT2AHTT | |
| SCHEMBL22931682 | 0.72 | MEN1 (0.52) | SMN1; SMN2HPGDMEN1KMT2AHTT | |
| Benzene SCHEMBL14537401 | 0.72 | MEN1 (0.52) | SMN1; SMN2HPGDMEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309366-A1 | COMPOUND, SENSOR, SENSOR EMBEDDED DISPLAY PANEL, AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| EP-3613504-A1 | PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS | Johnson Matthey Public Limited Company (GB) | 2020-02-26 | — | — | EP | disclosed |
| EP-2585216-B1 | PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS | JOHNSON MATTHEY PLC (GB) | 2019-11-20 | — | — | EP | disclosed |
| US-10167305-B2 | Allyl complexes for use in coupling reactions | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2019-01-01 | — | — | US | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-20130165660-A1 | COMPLEXES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-27 | — | — | US | disclosed |
| CN-103037969-A | Complexes | JOHNSON MATTHEY PLC | 2013-04-10 | — | — | CN | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| EP-2129788-A2 | LUMINESCENT COMPOUNDS | Seta Biomedicals, LLC (US) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008094637-A2 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS. LLC (US) | 2008-08-07 | — | — | WO | disclosed |
| EP-0977087-B1 | Electrophotographic apparatus | CANON KK (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-1732923-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005099706-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-10-27 | — | — | WO | disclosed |
| CN-1287117-A | Cyclobutene derivatives, preparation method and therapeutic use thereof | SANKYO CO (JP) | 2001-03-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | NPC1 2862/4885RAB9A 2402/4885SMN1; SMN2 4042/4885 |
| US-20230309366-A1 | COMPOUND, SENSOR, SENSOR EMBEDDED DISPLAY PANEL, AND ELECTRONIC DEVICE | ESR1, GPER1, ASIC1 | NPC1 3774/4885RAB9A 1654/4885SMN1; SMN2 2007/4885 |
| US-10167305-B2 | Allyl complexes for use in coupling reactions | AP3M1, AP1M1, C9 | NPC1 1817/4885RAB9A 2029/4885SMN1; SMN2 3644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.